Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21328364 | 0.93 | CA2 (0.53) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL21328361 | 0.92 | CA2 (0.52) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL21328358 | 0.92 | CA2 (0.52) | CA2ATMKDM4EALDH1A1PPARG | |
| Dodecane SCHEMBL11158478 | 0.90 | EPHX2 (0.51) | CA2ATMKDM4EPPARGPPARA | |
| SCHEMBL27612963 | 0.88 | ATM (0.75) | CA2ATMKDM4EPOLBCYP19A1 | |
| SCHEMBL28274696 | 0.88 | SMN1; SMN2 (0.49) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL7315399 | 0.88 | CALM1 (0.56) | CA2KDM4EALDH1A1PIK3CDPIK3CA | |
| SCHEMBL7253321 | 0.88 | PDE4A (0.52) | CA2KDM4EALDH1A1 | |
| SCHEMBL7367373 | 0.86 | CA2 (0.46) | CA2ATMKDM4EALDH1A1PPARG | |
| SCHEMBL6361965 | 0.85 | CA2 (0.44) | CA2ATMKDM4EALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132108-A1 | PREPARATION OF MESEMBRINE | KANNA HEALTH LTD (GB) | 2026-05-14 | — | — | US | claimed |
| EP-4614641-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-10 | — | — | EP | claimed |
| EP-4611093-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| EP-4611095-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| EP-4611154-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK Innovation Co., Ltd. (KR) | 2025-09-03 | — | — | EP | claimed |
| US-20250273821-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK IE TECHNOLOGY CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273741-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK IE TECHNOLOGY CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273816-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK INNOVATION CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| US-20250273815-A1 | ELECTROCHEMICAL DEVICE INCLUDING POROUS SEPARATOR | SK INNOVATION CO., LTD. (KR) | 2025-08-28 | — | — | US | claimed |
| EP-4598904-A1 | PREPARATION OF MESEMBRINE | Kanna Health Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| US-20020120164-A1 | Process for the preparation of 1-[cyano(aryl)methyl] cyclohexanol | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2002-08-29 | — | — | US | claimed |
| US-5840981-A | CATALYTICALLY HYDROGENATING 3,4-DIMETHOXYPHENYLACETONITRILE WITH A METHYLAMINE | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-24 | — | — | US | claimed |
| CN-1019972-C | Process for preparing 5, 6-dihydroxyindoles and 3-alkyl derivatives and intermediate compounds thereof | OREAL (FR) | 1993-03-03 | — | — | CN | claimed |
| EP-0211271-B1 | PROCESS FOR THE PREPARATION OF VERATRYL CYANIDE | BASF Aktiengesellschaft (DE) | 1988-10-12 | — | — | EP | claimed |
| CN-87107372-A | Process for preparing 5, 6-dihydroxyindoles and 3-alkyl derivatives and intermediate compounds thereof | — | 1988-08-03 | — | — | CN | claimed |
| US-4661610-A | Preparation of veratryl cyanide | BASF AKTIENGESELLSCHAFT (DE) | 1987-04-28 | — | — | US | claimed |
| EP-0211271-A1 | Process for the preparation of veratryl cyanide | BASF Aktiengesellschaft (DE) | 1987-02-25 | — | — | EP | claimed |
| EP-0142070-B1 | PROCESS FOR THE PREPARATION OF N-METHYLHOMOVERATRYL AMINE | BASF Aktiengesellschaft (DE) | 1986-07-09 | — | — | EP | claimed |
| EP-0142070-A1 | Process for the preparation of N-methylhomoveratryl amine | BASF Aktiengesellschaft (DE) | 1985-05-22 | — | — | EP | claimed |
| US-4201632-A | Separation of phenol-, cyclohexanone-, and cyclohexylbenzene-containing mixtures employing a nitrile as extraction distillation solvent | PHILLIPS PETROLEUM COMPANY (US) | 1980-05-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132108-A1 | PREPARATION OF MESEMBRINE | BHMT, TMSB10, MSMO1 | CA2 589/4885ATM 4465/4885KDM4E 561/4885 |
| US-20020120164-A1 | Process for the preparation of 1-[cyano(aryl)methyl] cyclohexanol | CYP2S1, C1S, CYP1B1 | CA2 2452/4885ATM 1878/4885KDM4E 1364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.